Biomarker panels for predicting prostate cancer outcomes

US10407731B2 · kind B2 · utility

Assignee

• Mayo Foundation for Medical Education and Research · US

Inventors

• George G. Klee · Cincinnati, US
• Robert B. Jenkins · Rochester, US
• Thomas M. Kollmeyer · Rochester, US
• Karla V. Ballman · Northfield, US
• Eric J. Bergstralh · Mazeppa, US
• Bruce W. Morlan · Northfield, US
• S. Keith Anderson · Rochester, US
• Tohru Nakagawa · Tokyo, JP

Key dates

• Filing date: Sep 17, 2015
• Grant date: Sep 10, 2019
• Expiry date: Mar 20, 2037

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12Q2600/16
• WIPO field: Medical technology
• WIPO sector: Instruments

Abstract

This document provides methods and materials related to assessing male mammals (e.g., humans) with prostate cancer. For example, methods and materials for predicting (1) which patients, at the time of PSA reoccurrence, will later develop systemic disease, (2) which patients, at the time of retropubic radial prostatectomy, will later develop systemic disease, and (3) which patients, at the time of systemic disease, will later die from prostate cancer are provided.